NEW YORK, NY / ACCESSWIRE / December 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of BioAge Labs, ...
BioAge Labs (BIOA) closed down more than -76% after it discontinued a Phase-2 trial evaluating its azelaprag drug for treating obesity. Sofi Technologies (SOFI) closed down more than -2% after Bank of ...
BioAge Labs (BIOA) is down more than -75% after it discontinued a Phase-2 trial evaluating its azelaprag drug for the treatment of obesity. Arthur J Gallagher (AJG) is down more than -1% after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback